Published in J Neurosci on November 21, 2007
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science (2012) 6.69
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest (2010) 1.66
Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol (2008) 1.66
Short-term sprint interval training increases insulin sensitivity in healthy adults but does not affect the thermogenic response to beta-adrenergic stimulation. J Physiol (2010) 1.49
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) (2009) 1.34
Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation. Diabetes (2008) 1.19
Hypothalamic glucagon signaling inhibits hepatic glucose production. Nat Med (2013) 1.11
Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci (2011) 1.11
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes (2008) 1.07
Central resistin overexposure induces insulin resistance through Toll-like receptor 4. Diabetes (2012) 1.01
Endoplasmic reticulum stress regulates adipocyte resistin expression. Diabetes (2009) 0.97
Dorsomedial hypothalamic NPY and energy balance control. Neuropeptides (2012) 0.95
Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice. J Neurosci (2013) 0.94
Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. Endocrinology (2008) 0.92
Brain-gut-adipose-tissue communication pathways at a glance. Dis Model Mech (2012) 0.90
Adipose "talks" to distant organs to regulate insulin sensitivity and vascular function. Obesity (Silver Spring) (2010) 0.90
Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin? Arthritis Res Ther (2013) 0.80
Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve Activity. Front Physiol (2015) 0.78
Neuroinflammation in overnutrition-induced diseases. Vitam Horm (2013) 0.78
Diabetic cardiomyopathy: is resistin a culprit? Cardiovasc Diagn Ther (2015) 0.77
Anorexia of aging and gut hormones. Aging Dis (2013) 0.76
Knockdown of Neuropeptide Y in the Dorsomedial Hypothalamus Promotes Hepatic Insulin Sensitivity in Male Rats. Endocrinology (2016) 0.75
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science (2012) 6.69
The many faces of PPARgamma. Cell (2005) 6.24
A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science (2011) 5.91
Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell (2002) 5.19
Functional improvement of dystrophic muscle by myostatin blockade. Nature (2002) 5.10
High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology (2009) 5.08
PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev (2008) 4.83
Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol (2011) 4.72
Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science (2007) 4.68
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008) 4.56
Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev (2007) 4.23
Physiology. The health risk of obesity--better metrics imperative. Science (2013) 4.19
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest (2004) 4.16
Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev (2008) 3.90
Regulation of fasted blood glucose by resistin. Science (2004) 3.54
Resistin is an inflammatory marker of atherosclerosis in humans. Circulation (2005) 3.52
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48
Adiponectin acts in the brain to decrease body weight. Nat Med (2004) 3.47
New developments in adipogenesis. Trends Endocrinol Metab (2009) 3.44
Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev (2005) 3.30
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature (2008) 3.23
A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med (2002) 3.22
HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci (2011) 3.06
RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A (2004) 3.05
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med (2012) 2.86
Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes Dev (2012) 2.83
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science (2006) 2.62
Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab (2001) 2.54
An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med (2004) 2.51
Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab (2007) 2.48
Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol Cell Biol (2010) 2.47
The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol Endocrinol (2005) 2.36
Propagation of adipogenic signals through an epigenomic transition state. Genes Dev (2010) 2.23
International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev (2006) 2.22
Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab (2005) 2.15
The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol (2003) 2.15
Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol (2007) 2.10
The current biology of resistin. J Intern Med (2004) 2.06
International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev (2006) 2.04
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci (2004) 1.97
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. J Cell Biol (2003) 1.92
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med (2012) 1.87
CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol (2007) 1.87
Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab (2010) 1.85
Clocks, metabolism, and the epigenome. Mol Cell (2012) 1.84
Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. Gastroenterology (2007) 1.76
The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1. J Biol Chem (2006) 1.73
A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev (2006) 1.70
Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol (2008) 1.66
Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest (2006) 1.66
Inhibition of ADRP prevents diet-induced insulin resistance. Am J Physiol Gastrointest Liver Physiol (2008) 1.64
Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest (2009) 1.63
A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J (2003) 1.62
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab (2007) 1.61
Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell (2003) 1.60
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature (2013) 1.59
Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem (2005) 1.57
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes (2003) 1.55
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev (2011) 1.54
Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev (2002) 1.53
Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology (2003) 1.53
Human resistin: found in translation from mouse to man. Trends Endocrinol Metab (2011) 1.51
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas. Mol Endocrinol (2009) 1.49
PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J Clin Invest (2005) 1.49
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab (2010) 1.48
Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J Clin Invest (2011) 1.46
Bifunctional role of Rev-erbalpha in adipocyte differentiation. Mol Cell Biol (2008) 1.45
Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes (2011) 1.44
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nat Struct Mol Biol (2013) 1.43
Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes (2004) 1.42
GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS Chem Biol (2010) 1.41
Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes (2006) 1.40
Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes (2004) 1.39
Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2. Mol Endocrinol (2002) 1.37
Inflamed about obesity. Nat Med (2004) 1.37
Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proc Natl Acad Sci U S A (2005) 1.35
ETO interacting proteins. Oncogene (2004) 1.35
Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol (2010) 1.31
Negative feedback maintenance of heme homeostasis by its receptor, Rev-erbalpha. Genes Dev (2009) 1.30
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest (2012) 1.29
Dissociating fatty liver and diabetes. Trends Endocrinol Metab (2012) 1.29
Brown fat in humans: turning up the heat on obesity. Diabetes (2009) 1.28
The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep (2005) 1.28
Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation. Nat Med (2008) 1.27
Activation of SOCS-3 by resistin. Mol Cell Biol (2005) 1.27
Nuclear receptor Rev-erbalpha: a heme receptor that coordinates circadian rhythm and metabolism. Nucl Recept Signal (2010) 1.27
The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control (2013) 1.26
Species-specific strategies underlying conserved functions of metabolic transcription factors. Mol Endocrinol (2011) 1.25
Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype. J Biol Chem (2009) 1.24
Mechanisms regulating adipocyte expression of resistin. J Biol Chem (2002) 1.24
Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. Proc Natl Acad Sci U S A (2013) 1.24
Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes (2006) 1.23
E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha. Proc Natl Acad Sci U S A (2010) 1.23
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol (2007) 1.22
Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms (2009) 1.19